Cargando…

Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4‐ROS‐ADAM17 pathway

Rutaecarpine attenuates hypertensive cardiac hypertrophy in the rats with abdominal artery constriction (AAC); however, its mechanism of action remains largely unknown. Our previous study indicated that NADPH oxidase 4 (Nox4) promotes angiotensin II (Ang II)‐induced cardiac hypertrophy through the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Si‐yu, Yang, Li, Lu, Hui‐qin, Yan, Qiu‐jiang, Gao, Ling, Qin, Xu‐ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533562/ https://www.ncbi.nlm.nih.gov/pubmed/30953402 http://dx.doi.org/10.1111/jcmm.14308

Ejemplares similares

A Reduction in ADAM17 Expression Is Involved in the Protective Effect of the PPAR-α Activator Fenofibrate on Pressure Overload-Induced Cardiac Hypertrophy
por: Zeng, Si-Yu, et al.
Publicado: (2018)

Rutaecarpine Ameliorates Pressure Overload Cardiac Hypertrophy by Suppression of Calcineurin and Angiotensin II
por: Li, Shujun, et al.
Publicado: (2021)

Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2
por: Zeng, Si-yu, et al.
Publicado: (2020)

NOX- and ROS-Driven Hypertension in Elastin Insufficiency
por: Gavazzi, Gaëtan, et al.
Publicado: (2021)

Progress in the Studies on Rutaecarpine
por: Lee, Seung Ho, et al.
Publicado: (2008)

Bellidifolin ameliorates isoprenaline-induced cardiac hypertrophy by the Nox4/ROS signalling pathway through inhibiting BRD4
por: Zhou, Dingyan, et al.
Publicado: (2023)

Involvement of shedding induced by ADAM17 on the nitric oxide pathway in hypertension
por: da Silva, Mirelly Cunha, et al.
Publicado: (2022)

Nox2 Deficiency Prevents Hypertension-Induced Vascular Dysfunction and Hypertrophy in Cerebral Arterioles
por: Chan, Siu-Lung, et al.
Publicado: (2013)

Evidence That ADAM17 Mediates the Protective Action of CGRP against Angiotensin II-Induced Inflammation in Vascular Smooth Muscle Cells
por: Zeng, Si-yu, et al.
Publicado: (2018)

ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK‐AKT Signaling
por: Xiang, Mei, et al.
Publicado: (2018)

Enhanced transdermal delivery of evodiamine and rutaecarpine using microemulsion
por: Zhang, Yong-Tai, et al.
Publicado: (2011)

ADAM17-Mediated Shedding of Inflammatory Cytokines in Hypertension
por: de Queiroz, Thyago M., et al.
Publicado: (2020)

Time effect of rutaecarpine on caffeine pharmacokinetics in rats
por: Estari, Rohit Kumar, et al.
Publicado: (2021)

Promising derivatives of rutaecarpine with diverse pharmacological activities
por: Li, Deping, et al.
Publicado: (2023)

Involvement of TRPV1 in the expression and release of calcitonin gene-related peptide induced by rutaecarpine
por: Yang, Yongmei, et al.
Publicado: (2018)

Identification of CDPKs involved in TaNOX7 mediated ROS production in wheat
por: Hu, Chun-Hong, et al.
Publicado: (2023)

In vitro cellular uptake of evodiamine and rutaecarpine using a microemulsion
por: Zhang, Yong-Tai, et al.
Publicado: (2012)

(±)-Evodiakine, A Pair of Rearranged Rutaecarpine-Type Alkaloids From Evodia rutaecarpa
por: Li, Yan-Hong, et al.
Publicado: (2016)

Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway
por: Chen, Youming, et al.
Publicado: (2020)

Neuroprotective effects of rutaecarpine on cerebral ischemia reperfusion injury
por: Yan, Chunlin, et al.
Publicado: (2013)

Pharmacological Effects of Rutaecarpine as a Cardiovascular Protective Agent
por: Jia, Sujie, et al.
Publicado: (2010)

Effects of Oral Rutaecarpine on the Pharmacokinetics of Intravenous Chlorzoxazone in Rats
por: Bista, Sudeep R., et al.
Publicado: (2008)

NOX-like ROS production by glutathione reductase
por: Diaz, Julia M., et al.
Publicado: (2022)

NOX Dependent ROS Generation and Cell Metabolism
por: Pecchillo Cimmino, Tiziana, et al.
Publicado: (2023)

ADAM 17 endopeptidase
Publicado: (2009)

Cardiac Hypertrophy Involves Both Myocyte Hypertrophy and Hyperplasia in Anemic Zebrafish
por: Sun, Xiaojing, et al.
Publicado: (2009)

Statins attenuate cholesterol-induced ROS via inhibiting NOX2/NOX4 and mitochondrial pathway in collecting ducts of the kidney
por: Wang, Ani, et al.
Publicado: (2022)

ADAM10 and ADAM17: New Players in Trastuzumab Resistance
por: Duffy, Michael J., et al.
Publicado: (2014)

ADAM10 and ADAM17—Novel Players in Retinoblastoma Carcinogenesis
por: Van Meenen, Dario, et al.
Publicado: (2022)

Naringenin Attenuates Isoprenaline-Induced Cardiac Hypertrophy by Suppressing Oxidative Stress through the AMPK/NOX2/MAPK Signaling Pathway
por: Li, Yu, et al.
Publicado: (2023)

Hyperhomocysteinemia Promotes Cardiac Hypertrophy in Hypertension
por: Deng, Yawen, et al.
Publicado: (2022)

Association of MiRNA122 & ADAM17 with Lipids among Hypertensives in Nigeria
por: Meka, Ijeoma A., et al.
Publicado: (2018)

Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats
por: Liu, Chi, et al.
Publicado: (2018)

ADAM17 knockdown mitigates while ADAM17 overexpression aggravates cardiac fibrosis and dysfunction via regulating ACE2 shedding and myofibroblast transformation
por: Cheng, Jing, et al.
Publicado: (2022)

The Downregulation of ADAM17 Exerts Protective Effects against Cardiac Fibrosis by Regulating Endoplasmic Reticulum Stress and Mitophagy
por: Guan, Chang, et al.
Publicado: (2021)

Progress in Studies on Rutaecarpine. II.—Synthesis and Structure-Biological Activity Relationships
por: Son, Jong-Keun, et al.
Publicado: (2015)

Electrosynthesis of polycyclic quinazolinones and rutaecarpine from isatoic anhydrides and cyclic amines
por: Chen, Xingyu, et al.
Publicado: (2020)

Evodiamine and Rutaecarpine as Potential Anticancer Compounds: A Combined Computational Study
por: Liu, Jingli, et al.
Publicado: (2022)

Rutaecarpine suppresses the proliferation and metastasis of colon cancer cells by regulating the STAT3 signaling
por: Chan, Shixin, et al.
Publicado: (2022)

Role of ADAM10 and ADAM17 in Regulating CD137 Function
por: Seidel, Jana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4gm7ju097u7n8kv6rarfqp0lg6